A new core laboratory at the University of Kansas will enhance the speed, quantity and quality of research into infectious diseases, neurological disorders, cancer and immunology.
Joanna Slusky, Associate Professor in the Department of Molecular Biosciences at the University of Kansas, received a four-year grant from the National Institute of General Medical Sciences with a total cost of $1,244,968.
New Grasp of Key COVID-19 Protein May Lead to a Live-Attenuated Vaccine Effective Against More Variants For Longer
Research from the University of Kansas just published in Proceedings of the National Academy of Sciences could hasten development of a new class of vaccines aimed at SARS-CoV-2, the virus that causes COVID-19.
Congratulations to Dr. Anthony Fehr, Molecular Biosciences, for his most recent publication.